PE Raids Roche

Premium

PE’s recent raid of the upper ranks of Roche’s diagnostics division was likely a sign of what’s to come.

Last month PE reeled in three Roche execs who will ramp up the company’s molecular diagnostics division. Kathy Ordonez, who oversaw Roche Molecular’s rise to dominance in the PCR arena over the last nine years, is bringing two colleagues with her to PE: Tom White, Roche Molecular’s vice president of R&D, and John Sinensky, its vice president of genetics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.